Co-Diagnostics receives CE Mark for Novel Coronavirus Test
Co-Diagnostics is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Feb 20
Co-Diagnostics is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology
24 Feb 20
The Fist Assist device offers a patient focused evidence based approach to surgical vein enhancement for all types…
20 Feb 20
Aquilion ONE / PRISM Edition integrates artificial intelligence technology to optimise conventional and spectral CT capabilities with automated…
20 Feb 20
EndoClot SIA is the first starch-derived submucosal injection system cleared in the U.S. market for endoscopic removal of…
19 Feb 20
SuperMap's user interface effortlessly guides electrophysiologists to quickly create exquisitely detailed whole-chamber maps of the left or right…
18 Feb 20
The CE Mark approval was based on data from two European clinical studies evaluating safety and efficacy of…
17 Feb 20
Venus Bliss device can be used for the non-invasive lipolysis of the abdomen and flanks
14 Feb 20
The STIM onTrack technology works with the Orthofix Bone Growth Therapy devices. The mobile device app is an…
13 Feb 20
Q-NRG+ leverages indirect calorimetry (IC) technology, which is considered as gold standard for precise measurement of resting energy…
13 Feb 20
The expanded indication will enable Senhance system to treat paediatric patients above 10kg